Superworth

Neogenomics EPS NEO

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.40
Latest quarter, Q2 FY26
$0.02
Fiscal year 2025
−$0.84

Neogenomics' earnings per share was −$0.40 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.02.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.84n/a
FY2024−$0.62n/a
FY2023−$0.70n/a
FY2022−$1.16n/a
FY2021−$0.11−375%
FY2020$0.04−43%
FY2019$0.07+17%
FY2018$0.06n/a
FY2017−$0.15n/a
FY2016−$0.39n/a
FY2015−$0.04−300%
FY2014$0.02−60%
FY2013$0.05n/a
FY2012$0.00n/a
FY2011−$0.03n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.02n/a−$0.40
Q1 FY26−$0.13n/a−$0.77
Q4 FY25−$0.08n/a−$0.84
Q3 FY25−$0.21n/a−$0.88
Q2 FY25−$0.35n/a−$0.81
Q1 FY25−$0.20n/a−$0.61
Q4 FY24−$0.12n/a−$0.62
Q3 FY24−$0.14n/a−$0.61
Q2 FY24−$0.15n/a−$0.62
Q1 FY24−$0.21n/a−$0.66
Q4 FY23−$0.11n/a−$0.70
Q3 FY23−$0.15n/a−$0.77

Against its peers

Companies in Specialty Business Services nearest Neogenomics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
NEONeogenomics−$0.40
VVXV2X$2.90+32% a year
MHMcGraw Hill$0.50
DFINDonnelley Financial Solutions$1.45−49% a year
CRAICRA International$7.51−9% a year
ITGartner$11.14−31% a year
ULSUL Solutions$2.48+53% a year
Peer median$2.69

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Neogenomics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.